Additive Effects of Jacobson's Progressive Muscle Relaxation Technique With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive Individuals
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Systolic and diastolic blood pressure
Study Overview
Brief Summary
The study is a randomized controlled trial. The purpose of study is to compare the additive effects of Jacobson's progressive muscle relaxation technique with aerobic exercise versus aerobic exercise on cardiopulmonary parameters including systolic and diastolic blood pressure, heart rate, respiratory rate, rate pressure product and quality of life in stage 1 hypertensive individuals.
Detailed Description
The study will consist of referred stage 1 hypertensive patients by medical specialist/cardiologist.
Participants will be screened through PAR-Q and IPAQ Questionnaire. Cardiac monitor will be used for assessing the cardiopulmonary parameters. SF-36 Questionnaire will be used for assessing the quality of life. Informed written consent will be taken after which participants will be recruited into two groups.
Control group will be provided aerobic exercise while interventional group will be provided Jacobson's progressive muscle relaxation technique with aerobic exercise.
Outcome measures assessment will be done at pre-session, at 2 weeks and after 4 weeks post-intervention
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 45 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adults: aged (18-45 years)
- •Gender: both male and female
- •Patients diagnosed with stage 1 hypertension (130-139 / 80-89 mmHg according to AHA/ACC 2017 guidelines
- •Mild to moderate physical activity level on IPAQ Questionnaire
- •Individuals who are able to understand and follow the instructions for exercise
Exclusion Criteria
- •Unstable angina, MI, heart failure, advanced CAD patients
- •Severe neurological, musculoskeletal, or gynaecological conditions which limit participation in study
- •Recent history of fracture
- •Morbidly obese (BMI > 40.0 kg / m2)
Arms & Interventions
Interventional group
Patients in interventional group will receive Jacobson's progressive muscle relaxation technique for 15 minutes and aerobic exercise for 30 minutes.
For Jacobson's progressive muscle relaxation technique first patient is asked to clench each fist separately, fee the tension, release the fist and relax. Then bend each arm separately, feel the tension and then release the arm. Then straighten the arm separately, feel the tension and then relax. Then wrinkle the forehead, feel the tension and then release the eyebrows relax. Then close the eyes and screw the muscles around the eyes and then release. Then tense the jaw by biting the teeth together and relax. Then press the tongue hard and flat against roof of mouth, feel the tension and then relax. Then push the head back and then bring head back to position. Then bring the head down and then relax. Then shrug the shoulders and relax. Then take a deep breath, hold and then relax. Then tense the stomach muscle and then release. Then arch
Intervention: Interventional group: Jacobson's progressive muscle relaxation technique with aerobic exercise (Other)
Control group
The control group will receive only aerobic exercise for 45 minutes. Aerobic exercise will include warm uo exercises for 5 minutes, brisk walking on treadmill for 25 minutes which include warm up period for 10 minutes then 14 minutes brisk walk and cool down period included 1 minute walk, stepper for 5 minutes, static cycling for 5 minutes and cool down for 5 minutes.
Total 4 weeks protocol. Before and after 4 weeks, pre and post intervention values will be taken.
A total of 20 sessions five days per week for 4 weeks will be provided supervised by physiotherapist
Intervention: Aerobic Exercise (Other)
Outcomes
Primary Outcomes
Systolic and diastolic blood pressure
Time Frame: 04 Weeks
Evaluation will be done using cardiac monitor for blood pressure.
Heart rate
Time Frame: 04 Weeks
It will be measured through pulse oximeter.
Respiratory rate
Time Frame: 04 Weeks
It will be measured by counting the number of breaths a person takes per minute
Rate pressure product
Time Frame: 04 Weeks
It will be calculated by multiplying heart rate with systolic blood pressure
Secondary Outcomes
No secondary outcomes reported